Reaction

Orthostatic Hypertension reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 578 reports · 21 co-occurring drugs

As of the last recalculation, Orthostatic Hypertension appears in 578 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is OLANZAPINE PAMOATE (PRR 98.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Olanzapine Pamoate9498.698.8
Quetiapine Fumarate6386.286.3
Aripiprazole Oral7069.269.3
Aripiprazole Orally Disintegrating7069.269.3
Asenapine Maleate1355.255.3
Olanzapine11346.846.9
Ziprasidone2246.746.8
Aripiprazole12345.745.7
Cariprazine1039.439.4
Rasagiline Mesylate826.226.2
Brexpiprazole919.819.8
Droxidopa1118.718.7
Levodopa618.118.1
Lurasidone Hydrochloride915.715.7
Carbidopa And Levodopa1914.914.9
Abaloparatide1113.713.7
Paliperidone812.512.5
Paliperidone Palmitate1011.411.4
Pimavanserin Tartrate128.08.0
Pirfenidone87.27.2
Valbenazine34.34.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.